New article presenting results of MEDICEM R&D team published
MEDICEM again participated at ESCRS, the main European ophthalmology event
Lisbon Oct 7-11 2017
WIOL-CF presented at ESCRS, the biggest European ophthalmology congress
Copenhagen, Sep 9-13 2016
WIOL-CF® PRESENTED AT IMPORTANT GERMAN OPHTHALMIC CONGRESS
29th International Congress of German Ophthalmic Surgeons was held in Nürnberg from June 9 to June 11.
ASCRS 2016 NEW ORLEANS
ASCRS 2016 has been one of the most important conventions for Medicem. We had numerous contacts from Physicians and Industry, clearly indicating that the WIOL-CF is gaining more and more visibility and consensus among the ophthalmic in
MEDICEM among "Companies to Watch"
At the recent OIS/AAO meeting in Las Vegas, MEDICEM was selected as one of the “Companies to Watch” and was invited to showcase its technology through a video.
WIOL-CF® at ESCRS 2015 in Barcelona
MEDICEM partners with Woman Care Global (WCG) to market Dilapan-S in selected international markets
On July 13, 2015, MEDICEM has announced that it signed agreement with Woman Care Global (WCG) to market the Dilapan-S, Hygroscopic Cervical Dilator, in selected countries worldwide.
WIOL-CF at ASCRS/ASOA Congress in San DiegoApril, 2015
DILAPAN-S confirmed its superiority over Laminaria. New scientific evidence available.March 2015
DILAPAN-S videos introducing the product newly available.March 2015
New DILAPAN-S videos on YouTube
New size of biological cover XE-DERMA 10x25cm availableJanuary 2015
WIOL-CF in media: Forbes 01/2015 (Czech edition)January, 2015
Unique lens as Wichterle heritage
WIOL-CF received "2014 Innovation Award" from "The Ophthalmologist"December, 2014
WIOL-CF at XXXII. Congress of the ESCRS in LondonSeptember, 2014
DILAPAN-S: Results of prospective, multicentre data collection on use of the osmotic dilator Dilapan-S in labor prenductionAugust, 2014
Presented at: 23 rd European Congress of Obstetrics and Gynaecology, May 2014, Glasgow, UK. XXIV. European Congress of Perinatal Medicine, June 104, Florence, Italy. 13rd World Congress in Fetal Medicine, June-July, Nice, France.
WIOL-CF clinical results presented on ASCRS/ASOA in BostonApril, 2014
WIOL-CF concept and clinical results shared in two presentations during ASCRS/ASOA in Boston.
WIOL-CF in media: Cataract & Refractive Surgery TodayApril, 2014
April issue of Cataract & Refractive Surgery Today published a panel discussion on accommodating IOL designs and discussing surgeons´ expectations from this category of IOLs.
WIOL-CF in media: ESCRS EuroTimesMarch, 2014
WIOL-CF featured in ‘Accommodation’, one of the top stories in the issue.
The Society of Family Planning recommends DILAPAN-SFebruary, 2014
The Clinical Guidelines (2013–4) published by the Society of Family Planning recommend DILAPAN-S for D&E before 20 weeks’ gestation as one of the best methods of cervical preparation.
A randomized clinical study by the American College of Obstetricians and GynecologistsFebruary, 2014
A randomized clinical study entitled ‘Buccal Misoprostol Compared with Synthetic Osmotic Cervical Dilator before Surgical Abortion’ was carried out by the American College of Obstetricians and Gynecologists (2013) among 125 women.